HOME >> BIOLOGY >> NEWS
Severe Falciparum Malaria Increases In Honduras

Washington, Sept. 1, 1998--A dramatic increase has been reported in falciparum malaria in northern Honduras by a group of researchers writing in the current issue of the Pan American Journal of Public Health.

"Over the past few years there has been a striking increase in malaria in Honduras," the journal said. Reported cases rose from 52,110 in 1994 to 75,565 in 1996, a 45% increase in three years. The journal is published by the Pan American Health Organization.

Malaria is a significant cause of death and disease worldwide. Each year, malaria parasites infect between 300 and 500 million people and cause more than 2.7 million deaths. Plasmodium vivax is reported to be the infecting strain in some 98% of Honduran malaria cases, the journal said. "However, we recently documented a much higher proportionate increase of falciparum malaria in northern Honduras." This type of malaria is a much more severe form of the disease.

The authors, Carol J. Palmer and colleagues from the University of Miami School of Medicine and John F. Lindo of the University of the West Indies in Jamaica, said they investigated a recent outbreak in the Coln region, and tested residents of that area as well as the city of San Pedro Sula. They collected 202 blood samples and found that 47% were positive for malaria parasites. Plasmodium vivax, the milder form, was present in 79% of the infected rural patients and 100% of the infected city patients.

The more severe form, Plasmodium falciparum, was present in 21% of the rural patients, the journal said. In 1996, this form of malaria accounted for 3.5% of the malaria cases in that area.

Possible explanations include increased transmission by mosquitoes as a result of a long rainy season, an increase in the non-immune population, development of chloroquine resistance by Plasmodium falciparum parasites, and underdiagnosis, the authors said.

"The widespread development
'"/>

Contact: Daniel Epstein
epsteind@paho.org
(202) 974-3459
Pan American Health Organization
1-Sep-1998


Page: 1 2

Related biology news :

1. Severe depression associated with greater number of nerve cells in thalamus region of brain
2. Severe kidney disease in blacks linked to genes on two chromosomes
3. Severe Pain Following Shingles Safely Relieved In Clinical Trial Of Anti-Convulsant Drug Gabapentin
4. Scientists Find Gene For Severe Form Of Epilepsy
5. Common Anti-Viral Medication Prevents Severe Eye Herpes
6. Common Food Dye Can Cause Severe Allergic Reactions
7. Oral Vaccine Protects Infants From Severe Rotavirus Diarrhea
8. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
9. Malaria rise in Africa parallels warming trends
10. Pan-African Malaria Conference November 17-22 in Arusha, Tanzania
11. Multilateral Initiative on Malaria Secretariat to move to Sweden

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Severe Falciparum Malaria Increases Honduras

(Date:7/21/2015)... -- Today, ZTE announced its Android smartphone Axon, featuring ... revenues in 2015 that relate to sales of FPC1025 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... China and we are proud that ... Axon , its first ...
(Date:7/20/2015)...  Acuity Market Intelligence,s latest research "The Global ... and Privacy" forecasts that between 2014 and 2020 ... downloaded to smart mobile devices by 2.2 billion ... projected to generate more than $67.9 billion in ... period.    "Biometrics is at the ...
(Date:7/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the fourth quarter and ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-455-2260 ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
(Date:7/29/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ... an optimized Erk inhibitor molecule for development, thus ... a new class of potential cancer therapies. ... target for therapeutic intervention in cancer. Recently approved ... for B-Raf and Mek inhibitors. Erk inhibitors may ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... PRC Clinical, a Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi ... patient recruitment services. The core expertise of PRC Clinical is focused on Clinical ...
(Date:7/29/2015)... ... July 29, 2015 , ... Costello served as Lead ... to protect the Orange County, Texas area from future storm surge flooding, such ... in determining several potential levee alignment alternatives for providing protection, Costello also balanced socio-economic ...
(Date:7/29/2015)... ... July 29, 2015 , ... Asymmetrex, ... good progress in evaluating the full range of capabilities of its unique cache ... stem cells perform the day-to-day renewal and repair of normal tissues and organs. ...
Breaking Biology Technology:Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Preventing Storm Surge Flooding in Houston 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4
Cached News: